🔴 MiniMed Group is trading 5% down in pre-market with no clear catalyst

MiniMed Group is trading at $16.55, down 5.37% in pre-market; no clear company-specific catalyst has surfaced.

• Medtronic’s separation of MiniMed was completed on October 15, but that earlier event does not establish a direct catalyst for this move.
• Major U.S. indices were modestly higher. The cause of MiniMed Group’s decline remains unclear, and the separation is background rather than a confirmed explanation.